Last update 01 Jun 2025

SCB-1033

Overview

Basic Info

Drug Type
Recombinant protein, Prophylactic vaccine
Synonyms
Consists of four recombinant protein subunit antigens:RSV A strain+RSV B strain+ hMPV+PIV3, SCB-1019T(A)+SCB-1019T(B)+SCB-1021+SCB1020(Clover Biopharmaceuticals AUS Pty), SCB-1033(combination recombinant RSV-hMPV-PIV3 vaccine candidate)
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication
Human Metapneumovirus InfectionParainfluenzae virus infectionRespiratory Syncytial Virus Infections
Inactive Indication-
Originator Organization
Clover Biopharmaceuticals AUS Pty Ltd.
Active Organization
Clover Biopharmaceuticals AUS Pty Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SCB-1033
NCT06984094
/ Not yet recruitingPhase 1
A Phase 1, Randomized, Observer-blind, First-in-human Study to Describe the Safety, Reactogenicity and Immunogenicity of SCB-1022 and SCB-1033 in Healthy Older Adults Aged 60-85 Years
100 Clinical Results associated with SCB-1033
Login to view more data
100 Translational Medicine associated with SCB-1033
Login to view more data
100 Patents (Medical) associated with SCB-1033
Login to view more data
100 Deals associated with SCB-1033
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Human Metapneumovirus InfectionPhase 1
Australia
Clover Biopharmaceuticals AUS Pty Ltd.
31 May 2025
Parainfluenzae virus infectionPhase 1
Australia
Clover Biopharmaceuticals AUS Pty Ltd.
31 May 2025
Respiratory Syncytial Virus InfectionsPhase 1
Australia
Clover Biopharmaceuticals AUS Pty Ltd.
31 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free